Diabetes

By Jonah Comstock February 21, 2018
Implantable glucose sensor company Senseonics has launched a remote monitoring app for its users in Europe, the Middle East, and Africa, where its CGM system is distributed by Roche. The app, called Eversense Now, allows users of the sensor to select up to five friends or family members to view their glucose data, which is updated every five minutes. The feature is available for iOS users at the...
By Dave Muoio February 14, 2018
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA. The MIDS module allows clinicians to create a customized treatment plan and send it to Type 2 diabetes patients directly through the company’...
By Laura Lovett February 7, 2018
A new study from Cardiogram suggests that ordinary wearables like Fitbit and Apple watches can detect diabetes and other medical conditions when integrated with Cardiogram’s DeepHeart app.  “Twenty-four percent of people with diabetes, and 88.4 percent with pre-diabetes, don't realize they have it,” Brandon Ballinger, CEO of Cardiogram, told MobiHealthNews in an email. “We don't want to turn...
By Dave Muoio February 5, 2018
The Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexible, patch-based insulin pump for artificial pancreas systems. "JDRF is excited to partner with Cam Med on improving insulin delivery hardware,” Jaime Giraldo, program...
By Dave Muoio January 4, 2018
An analysis contracted by WellDoc found that the company’s digital therapeutic for Type 2 diabetes management could lead to an average savings of more than $250 per patient per month. “The cost of a well-controlled diabetes patient will typically range in the $13,000 range [to] $20,000 annually. When you contrast that with the cost of a patient that doesn’t have diabetes, that number is typically...
By Dave Muoio January 4, 2018
Mobile textile company Sensoria Health (an independent strategic partnership between Sensoria Fitness and Genesis Rehab Services) and diabetic mobility garment maker Optima Molliter are collaborating on a smart footwear product capable of measuring diabetes patients’ compliance to prescribed mechanical offloading protocols. “By combining the best innovations in diabetic footwear technology and...
By Laura Lovett November 30, 2017
A recent data analysis by Evidation Health found that by using wearables, researchers could track activity characteristics associated with co-morbid mental health illness symptoms among people with diabetes.  “Individuals with diabetes are at a higher risk of developing mental health illnesses than those without diabetes. This increased risk is partially due to the fact that diabetes is a...
By Dave Muoio November 29, 2017
A slew of digital diabetes care companies have announced integrations with the upcoming virtual Type 2 diabetes management platform being developed by Onduo, a joint venture of Verily and Sanofi. These announced services include Voluntis’ Insulia, a digital insulin dose recommendation and coaching system; Glytec’s Glucommander Outpatient, cloud-based software that evaluates blood glucose and...
By Laura Lovett November 27, 2017
San Diego-based Biolinq, a digital health company specializing in minimally invasive continuous glucose monitoring, raised $10 million in Series A financing. The round was led by M Ventures, in collaboration with Hikma Ventures.  Biolinq is currently working on a skin applied, minimally-invasive electrochemical biosensor platform for diabetes patients, which analyzes biomarkers in the...
By Jonah Comstock November 16, 2017
Medical device software company Voluntis has received an updated FDA clearance (as well as an updated CE mark) for its Insulia app, a "digital companion" app for people with Type 2 diabetes. Insulia offers realtime basal insulin dose coaching, and the new clearance makes the app usable with two additional brands of insulin: Basaglar and Tresiba. The app had already worked for users of Lantus,...